Literature DB >> 10352863

Pharmacy benefit management companies: dimensions of performance.

H L Lipton1, D H Kreling, T Collins, K C Hertz.   

Abstract

Research on pharmacy benefit management companies focuses on descriptive accounts of the organizations and the scope of their services. This review provides a critical analysis of publicly available research on contemporary issues surrounding the operations and effects of pharmacy benefit management companies. There has been very little systematic, empirical research on these issues; major questions concerning the impact of pharmacy benefit management companies on quality, costs, and patient outcomes remain unanswered. We analyze what is known and what needs to be known, and we explore major research challenges that lie ahead in the assessment of the pharmacy benefit management company's role in the health care system and in improving the public's health.

Entities:  

Mesh:

Year:  1999        PMID: 10352863     DOI: 10.1146/annurev.publhealth.20.1.361

Source DB:  PubMed          Journal:  Annu Rev Public Health        ISSN: 0163-7525            Impact factor:   21.981


  4 in total

1.  Policy statements adopted by the Governing Council of the American Public Health Association, November 15, 2000.

Authors: 
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

2.  Exploring the demand for a voluntary Medicare prescription drug benefit.

Authors:  Richard R Cline; David A Mott
Journal:  AAPS PharmSci       Date:  2003

Review 3.  A political history of medicare and prescription drug coverage.

Authors:  Thomas R Oliver; Philip R Lee; Helene L Lipton
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

4.  Developing Performance Measures for Prescription Drug Management.

Authors:  Anita J Chawla; Marjorie R Hatzmann; Stacey R Long
Journal:  Health Care Financ Rev       Date:  2001
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.